Last updated: March 15, 2026
What Is the Scope of Patent AU2014261336?
Patent AU2014261336 pertains to a pharmaceutical invention filed in Australia, with priority claimed from an earlier international application. The patent protects a specific formulation or method related to a drug, though exact details require review of the official document.
The scope includes:
- A detailed description of a drug composition or process.
- Specific molecular structures, dosage forms, or delivery mechanisms.
- Manufacturing processes or treatment methods linked to the active pharmaceutical ingredient (API).
- Claims structured to cover the drug's unique aspects and variations.
This patent aims to secure exclusive rights to the formulation or method, potentially spanning the treatment of a targeted disease or condition.
How Are the Claims Structured?
Types of Claims
The patent contains two primary categories:
- Product Claims: Cover specific chemical compounds, formulations, or dosage forms.
- Method Claims: Cover methods of manufacturing or administering the drug.
Claim Elements
The claims reference:
- Specific chemical structures or derivatives.
- Concentration ranges or ratios.
- Delivery methods, including routes of administration.
- Manufacturing steps, such as chemical synthesis or formulation procedures.
Scope Comparison
Compared to similar Australian patents, AU2014261336's claims are narrowly tailored to particular compounds with defined structures, limiting their scope to variants explicitly described. Broader claims are likely constrained by prior art, emphasizing specific features.
Limitations
- No claims extend to broad classes of compounds unless explicitly detailed.
- Method claims specify particular steps, which may be vulnerable if alternative methods are identified.
- Dependent claims narrow the scope further by referencing specific embodiments.
Patent Landscape in Australia for This Drug Class
Context
The Australian patent environment for pharmaceuticals is governed by the Patents Act 1990, with amendment and guidelines aligning with international standards. The landscape for drug patents includes:
- A high volume of filings from multinational pharmaceutics.
- A trend toward protecting chemical structures, formulations, and second-use indications.
- Strict novelty and inventive step requirements, especially for combination drugs or new uses.
Competitor Patents
Major generics companies and patent holders have filed numerous patents covering similar compounds or formulations. The landscape shows overlapping claims, often resulting in patent thickets, complicating freedom-to-operate analyses.
Prior Art & Patent Families
Key prior art includes earlier patents and publications that disclose similar chemical structures, formulations, or treatment methods prior to AU2014261336's priority date. Patent families linked to the original filings often extend protection into other jurisdictions, affecting regional freedom to operate.
Patent Term and Extensions
Standard patent term for pharmaceuticals in Australia is 20 years from the filing date, with possibilities for extensions via patent term adjustments linked to regulatory approval periods.
Recent Trends
- Increased filings for drug delivery platforms.
- Emphasis on formulations that improve stability, bioavailability, or patient compliance.
- Expanding protection via secondary and divisional patents to cover new indications or formulations.
Key Considerations for Patent Strategy
- Analyze whether the claims are sufficiently narrow to avoid infringement of overlapping patents.
- Investigate whether supplementary patent protections (SPCs) or extensions are available based on regulatory approval timelines.
- Assess possible competition from existing patents covering API synthesis or delivery mechanisms.
Summary of Patent AU2014261336
| Aspect |
Details |
| Filing date |
Approximate (based on patent numbering and procedures) |
| Priority date |
Earlier date (exact date requires official documents) |
| Patent term |
20 years from filing, with possible extensions |
| Claims |
Cover specific drug formulations and manufacturing methods |
| Scope |
Narrow to particular compounds and methods |
| Landscape status |
Fragmented with overlapping patents and prior art |
| Key competitors |
Multinational pharmaceutical companies and generics firms |
Key Takeaways
- The patent protects specific formulations or methods but is narrowly scoped.
- The landscape features overlapping patents and prior art, requiring detailed freedom-to-operate assessments.
- Strategic patent family expansion can extend the protective period.
- Australia's patent system aligns with international standards but emphasizes novelty and inventive step.
- Patent scope limitations could influence licensing, commercialization, or challenge strategies.
FAQs
1. How does the scope of AU2014261336 compare to similar patents?
Its scope is narrower, focusing on specific compounds and formulations, reducing the risk of overlap but also limiting broad protection.
2. What are the main risks in infringing existing Australian patents?
Overlap with prior art or overlapping claims can pose infringement risks, especially if competitor patents cover similar APIs or delivery methods.
3. Can the patent be challenged through validity proceedings?
Yes, third parties can file opposition or invalidity claims based on prior art or lack of inventive step.
4. How does the patent landscape affect market entry?
A crowded landscape with overlapping patents can delay market entry or require licensing agreements.
5. What strategies can extend patent protection beyond 20 years?
Applying for supplementary protection certificates (SPCs) or divisional patents linked to new uses or formulations.
References
-
Australian Patent Office. (2022). Patent law and practice. [Online]. Available: https://www.ipaustralia.gov.au/patents [Accessed: 2023-10-01].
-
World Intellectual Property Organization. (2020). Patent landscapes: Pharmacology. WIPO Publications.
-
Commonwealth of Australia. (1990). Patents Act 1990.
-
European Patent Office. (2021). Guidelines for examination of pharmaceutical patents.
-
patentlens.org. (2023). Patent search and landscape analysis tools [Online].
[1] Australian Patent Office. (2022). Patent law and practice.
